AstraZeneca Pharma India has informed that it enclosed the Postal Ballot Notice dated February 11, 2026, being sent to the members of the Company to their registered email addresses, seeking their approval for the special business as set out therein. The Notice is being sent to the members whose names appear in the Register of Members/ Record of Depositories as on the cut-off date being Friday, February 20, 2026. The e-voting period commences on Saturday, February 28, 2026 (9:00 am IST) and ends on Sunday, March 29, 2026 (05:00 pm IST). The Company has engaged the services of National Securities Depository for facilitating e-voting in a secure manner. The said information is also available on the website of the Company: www.astrazeneca.com/india.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: